RenovoRx RNXT
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
RenovoRx (RNXT) Core Market Data and Business Metrics
Latest Closing Price
$1Price-Earnings Ratio
-1.72Total Outstanding Shares
35.53 Million SharesDividend
No dividendSIC Description
Pharmaceutical PreparationsPrimary Exchange
NASDAQHeadquarters
2570 W. El Camino Real, Ste. 320,, Mountain View, CA, 94040
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 46,907 Shares | 4.03 | 3/14/2025 | 189,155 Shares |
| 130,180 Shares | 1.81 | 2/28/2025 | 235,192 Shares |
| 339,541 Shares | 1 | 2/14/2025 | 205,910 Shares |
| 150,517 Shares | 1 | 1/31/2025 | 128,115 Shares |
| 50,012 Shares | 2.6 | 1/15/2025 | 130,183 Shares |
| 71,926 Shares | 1.61 | 12/31/2024 | 115,525 Shares |
Cash Flow Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Operating Activities, Continuing | $-8.75 Million |
| Net Cash Flow From Investing Activities | $-8.39 Million |
| Net Cash Flow From Financing Activities, Continuing | $15.09 Million |
| Net Cash Flow | $-3.22 Million |
| Net Cash Flow From Financing Activities | $15.09 Million |
| Net Cash Flow From Investing Activities, Continuing | $-9.55 Million |
Income Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Net Income/Loss Attributable To Parent | $-9.16 Million |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0 |
| Basic Average Shares | $21.46 Million |
| Preferred Stock Dividends And Other Adjustments | $0 |
| Revenues | $0 |
| Diluted Average Shares | $21.46 Million |
Comprehensive Income
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss | $-9.16 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Other Comprehensive Income/Loss | $-17,000 |
| Comprehensive Income/Loss Attributable To Parent | $-9.16 Million |
Balance Sheet
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Liabilities | $2.96 Million |
| Liabilities And Equity | $10.03 Million |
| Current Assets | $10.03 Million |
| Current Liabilities | $1.77 Million |
| Equity Attributable To Noncontrolling Interest | $0 |
| Accounts Payable | $686,000 |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||